Back to Search Start Over

Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.

Authors :
Hanagiri T
Sugaya M
Takenaka M
Oka S
Baba T
Shigematsu Y
Nagata Y
Shimokawa H
Uramoto H
Takenoyama M
Yasumoto K
Tanaka F
Source :
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2011 Oct; Vol. 74 (1), pp. 112-7. Date of Electronic Publication: 2011 Mar 12.
Publication Year :
2011

Abstract

Purpose: This study investigated the preoperative serum levels of CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.<br />Subjects: This study evaluated 341 patients who had undergone a complete resection for stage I NSCLC between 2002 and 2008.<br />Results: The patients included 193 males and 148 females. The mean age of the patients was 69.2 years (range: 19-88). The histological types included 264 adenocarcinomas, 56 squamous cell carcinomas, 11 large cell carcinomas, and 10 other types of carcinoma. A pneumonectomy was performed in 2 patients, a bilobectomy in 7, a lobectomy in 255, a segmentectomy in 46, and partial resection of the lung in 31 patients. The positive rates for CYFRA 21-1 in the adenocarcinoma and squamous cell carcinoma patients were 33.3% and 76.8%, respectively. The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively. The 5-year survival rate after surgery in the normal CYFRA 21-1 group and the high CYFRA 21-1 groups were 92.8% and 75.4%, respectively, in the patients with stage I NSCLC. There was a significant difference between the 2 groups (p<0.0001). The 5-year survival rate according to the serum level of CEA in the patients with stage I NSCLC were 88.3% for the normal group and 76.3% for the high group. In a multivariate analysis using the variables found to be significant prognostic factors in univariate analysis, a high CYFRA 21-1 level was found to be a significant independent prognostic factor (95% confidence interval 1.213-5.442, p=0.014).<br />Conclusion: A high preoperative CYFRA 21-1 level was a significant independent prognostic factor in patients with stage I NSCLC. The patients with a high CYFRA 21-1 level should carefully followed-up to rule out occult metastasis. Further clinical studies will be necessary to evaluate the efficacy of adjuvant therapy for the patients selected according to this criterion.<br /> (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1872-8332
Volume :
74
Issue :
1
Database :
MEDLINE
Journal :
Lung cancer (Amsterdam, Netherlands)
Publication Type :
Academic Journal
Accession number :
21397974
Full Text :
https://doi.org/10.1016/j.lungcan.2011.02.001